project id: TCGA-SKCM; case submitter id: TCGA-EE-A2GO; source center: 23; state: released; a260 a280 ratio: 1.85; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.5; rna integrity number: 8.8; age at index: 66; days to birth: -24159; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1936; age at diagnosis: 24159; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T3b; ajcc staging system edition: 5th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 3857.0; icd 10 code: C49.2; last known disease status: not reported; morphology: 8730/3; primary diagnosis: Amelanotic melanoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Connective, subcutaneous and other soft tissues of lower limb and hip; synchronous malignancy: Not Reported; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 2002; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 3162; days to sample procurement: 0; initial weight: 70.0; portion submitter id: TCGA-EE-A2GO-06A-11; percent lymphocyte infiltration: 7.0; percent monocyte infiltration: 1.0; percent necrosis: 9.0; percent neutrophil infiltration: 1.0; percent normal cells: 0.0; percent stromal cells: 16.0; percent tumor cells: 75.0; percent tumor nuclei: 75.0;